Effect of orlistat on obese women with polycystic ovary syndrome
Abstract. Polycystic ovary syndrome (PCOS) is a common gynecological endocrine syndrome characterized by metabolic abnormality and reproductive dysfunction, including ovulation abnormality, hyperandrogenism and polycystic ovarian manifestations. Most PCOS patients are overweight or obese, particular...
Main Authors: | Qi Jiang, Yuhua Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health
2018-12-01
|
Series: | Journal of Bio-X Research |
Online Access: | http://journals.lww.com/10.1097/JBR.0000000000000017 |
Similar Items
-
Subclinical inflammation in obese women with polycystic ovary syndrome
by: Dina Gamal Eldeen Y. Elkholi, et al.
Published: (2012-09-01) -
The effect of exercise on insulin resistance in obese women with polycystic ovary syndrome
by: Heba S Kareem, et al.
Published: (2014-01-01) -
Lifestyle and environmental contributions to ovulatory dysfunction in women of polycystic ovary syndrome
by: Bingqian Zhang, et al.
Published: (2020-01-01) -
Endocrine and metabolic changes in women with polycystic ovaries and polycystic ovary syndrome
by: Koivunen, R. (Riitta)
Published: (2001) -
Reproductive and biochemical changes in obese and non obese polycystic ovary syndrome women
by: Manal Ibrahim Mahmoud, et al.
Published: (2015-03-01)